-
1 Comment
Novozymes A/S is currently in a long term uptrend where the price is trading 19.0% above its 200 day moving average.
From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 8.2.
Novozymes A/S's total revenue sank by 7.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 29.1% to $654M since the same quarter in the previous year.
Finally, its free cash flow grew by 399.3% to $754M since the same quarter in the previous year.
Based on the above factors, Novozymes A/S gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
Sector | Basic Materials |
Industry | Specialty Chemicals |
ISIN | DK0060336014 |
Target Price | None |
---|---|
Dividend Yield | 1.5% |
Beta | 0.56 |
Market Cap | 25B |
PE Ratio | 81.31 |
Novonesis A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, and sewage, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NZM2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025